According to a recent SEC filing, PanTheryx has raised $8.9 million in financing from an undisclosed investor.
PanTheryx is a U.S. medical nutrition company focused on the research, development, and commercialization of products that promote intestinal health. The company is engaged in the discovery and development of its proprietary technology platform, advancing clinical testing, and commercialization of its products, addressing the specific dietary needs of children with infectious diarrhea as well as supporting overall intestinal health.